Structure–Function Relationships in Geographic Atrophy Based on Mesopic Microperimetry, Fundus Autofluorescence, and Optical Coherence Tomography
These findings provide insights into the complex relationship between retinal structure and visual function and contribute to a nuanced understanding of outcome measures.
Authors
- Alisa T. Thavikulwat (ORCID: https://orcid.org/0000-0001-6545-3156)
- Clare Bailey (ORCID: https://orcid.org/0000-0003-2141-4512)
- Maximilian Pfau (ORCID: https://orcid.org/0000-0001-9761-9640)
- Tharindu De Silva (ORCID: https://orcid.org/0000-0002-2882-4920)
- Srinivas R. Sadda (ORCID: https://orcid.org/0000-0002-4939-3306)
- Sunil Bellur (ORCID: https://orcid.org/0000-0002-0666-0021)
- Tiarnán D L Keenan (ORCID: https://orcid.org/0000-0002-2253-1772)
- Wai T. Wong (ORCID: https://orcid.org/0000-0003-0681-4016)
- M. Roselle Abraham (ORCID: https://orcid.org/0000-0002-7989-2210)
- Thilaka Arunachalam
- Christine M. Orndahl
- Souvick Mukherjee (ORCID: https://orcid.org/0000-0003-0748-8371)
- Elvira Agrón (ORCID: https://orcid.org/0000-0002-2829-4042)
- Emily Y. Chew (ORCID: https://orcid.org/0000-0003-0999-9802)
- Brett G. Jeffrey (ORCID: https://orcid.org/0000-0001-9549-0644)
- Cameron Duic (ORCID: https://orcid.org/0000-0001-5075-0203)
- Supriya Menezes
Institutions
- National Institutes of Health (US)
- University of California, Los Angeles (US)
- University Hospital of Basel (CH)
- Doheny Eye Institute (US)
- Bristol Eye Hospital (GB)
- Emmes (United States) (US)
- National Eye Institute (US)
- Institute of Molecular and Clinical Ophthalmology Basel (CH)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1167/tvst.14.2.7
- Citations
- 7
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 11.95
Funders
- U.S. Department of Health and Human Services
- Amgen
- Sanofi
- Biogen
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Regeneron Pharmaceuticals
- Alimera Sciences
- Apellis Pharmaceuticals
- Inozyme Pharma
- Carl Zeiss Meditec AG
- Astellas Pharma
- National Institutes of Health
- Genentech
- Samsung
- Allergan
- Janssen Research and Development